Engineering immunomodulatory biomaterials for type 1 diabetes
CL Stabler, Y Li, JM Stewart… - Nature Reviews Materials, 2019 - nature.com
A cure for type 1 diabetes (T1D) would help millions of people worldwide but remains
elusive to date. Tolerogenic vaccines and β-cell replacement therapy are complementary …
elusive to date. Tolerogenic vaccines and β-cell replacement therapy are complementary …
[HTML][HTML] Combinatorial islet protective therapeutic approaches in β‐cell transplantation: Rationally designed solutions using a target product profile
K Lu, T Brauns, AE Sluder, MC Poznansky… - FASEB …, 2023 - ncbi.nlm.nih.gov
While progress has been made in the development of islet cell transplantation (ICT) as a
viable alternative to the use of exogenous insulin therapy in the treatment of type 1 diabetes …
viable alternative to the use of exogenous insulin therapy in the treatment of type 1 diabetes …